Skip to main content
Signal8

Ma Yingli

SEC insider (Form 3/4/5 filer). CIK 0001963664. CHIEF TECHNOLOGY OFFICER at Structure Therapeutics Inc. (GPCR). 6 reported Form 4/5 transactions since Sep 2024; latest on Mar 19, 2026. Located in SOUTH SAN FRANCISCO, CA.

Companies Ma Yingli has filed insider reports for

  • Structure Therapeutics Inc. (GPCR): Officer, CHIEF TECHNOLOGY OFFICER
Ma Yingli profile photo

Ma Yingli

CIK: 0001963664

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Structure Therapeutics Inc. logo
GPCR

Structure Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Mar 19, 2026
    Award
    Direct
    32.5K shares-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Mar 3, 2026
    Tax Payment
    Direct
    11.3K shares at avg. $20.99$237K
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Jul 1, 2025
    Tax Payment
    Direct
    4.5K shares at avg. $6.84$31K
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Jul 1, 2025
    Award
    Direct
    24.5K shares-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Mar 15, 2025
    Award
    Direct
    63.8K shares-
  • Structure Therapeutics Inc. logo
    GPCR

    Structure Therapeutics Inc.

    Mar 1, 2025
    Tax Payment
    Direct
    1.8K shares at avg. $7.92$14K

1-6 of 6